---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-097591"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2025-07-22T23:59:59+00:00"
generated_at: "2026-05-18T04:06:50.823590+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics Corporate Secretary Melinda Lackey to depart August 15, 2025

## Summary
- Melinda Lackey notified company on 7/16/2025 of termination of consulting agreement effective 8/15/2025.
- She will resign as Legal and Administrative Officer and Corporate Secretary on the effective date.
- Departure not due to any disagreement with the company on operations, policies, or procedures.
- No additional severance beyond accrued but unpaid compensation through effective date.

## SEC filing metadata
- accession: 0000950170-25-097591
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2025-07-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017025097591/0000950170-25-097591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017025097591/tcrt-20250716.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-097591
- JSON: https://secwatch.observer/filing/0000950170-25-097591.json
- Plain text: https://secwatch.observer/filing/0000950170-25-097591.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.